TGI (Targeted Granzyme B Immunotherapy) Poster Presented at the 2018 AACR Annual MeetingBusiness Wire (press release)CHICAGO–(BUSINESS WIRE)–Dr. Michael Rosenblum and his team at MD Anderson Cancer Center, Houston, TX, presented updated data on TGI (… Continue reading
Science Daily |
New light shed on how bone marrow niches keep stem cells thriving
Science Daily “In the absence of Ebf3, the stem cell population dropped fairly sharply, consistent with CAR cells playing a major role HSC regulation,” Seike adds. “What we didn’t expect was the impact the removal would have on the shape of the niche itself. We … |
6abc.com |
Exton biotech testing gene therapy for devastating skin disorder
6abc.com A Chester County biotech firm now has the FDA’s OK to begin pediatric tests on its breakthrough drug. It could ease suffering for thousands with a devastating skin disorder known as RDEB. “As soon as he was born, they knew something was wrong … |
OncLive |
Immunotherapy Options in Refractory CRC
OncLive Transcript: John L. Marshall, MD: All right, let’s shift gears back to the sense of hope that’s out there and the new therapies that are emerging in refractory and other lines of therapy. Everybody’s favorite topic is, of course, immunotherapy. Johanna … |
OncLive |
Immunotherapy Options in Refractory CRC
OncLive Transcript: John L. Marshall, MD: All right, let’s shift gears back to the sense of hope that’s out there and the new therapies that are emerging in refractory and other lines of therapy. Everybody’s favorite topic is, of course, immunotherapy. Johanna … |